Cost of Gynaecological Cancer Treatment in IndiaSurgical Costs · Chemotherapy · Insurance · EMI · India vs World Comparison — 2026 Complete Guide
Transparent 2026 Surgical Tariff · Actual Chemotherapy Costs · EMI & Financing Options · Insurance Guidance · No Hidden Charges
⚡ Key Facts at a Glance — Cancer Treatment Costs in India
The moment a gynaecological cancer diagnosis is confirmed, the questions come quickly — and they are not only medical. What will this cost? Can my family afford this? Will insurance cover it? These are legitimate, important questions — and this guide answers every one of them clearly, in plain language, with actual numbers.
India occupies a uniquely advantageous position in the global cancer treatment landscape. Indian surgeons trained in Gynecologic Oncology deliver outcomes equivalent to their counterparts in the USA, UK, and Singapore — at a fraction of the cost. The gap is structural, not clinical.
At Shree Hospitals, cost transparency is a core value. All surgery estimates are provided in writing before the procedure. There are no hidden charges. What you are quoted is what you pay for the surgical component.
What This Guide Covers
The Shree Hospitals 2026 surgical tariff for gynaecological cancer surgery; chemotherapy costs in Tier 1 India; India vs international cost comparison; robotic surgery costs; insurance guidance; EMI and financing options; total treatment cost estimates by cancer type; and how to get your written cost estimate before committing to surgery.
Shree Hospitals 2026 Surgical Tariff — What Cancer Surgery Actually Costs
The table below presents the official Shree Hospitals surgical package rates for gynaecological cancer procedures, extracted directly from the 2026 tariff. These are all-inclusive surgery package rates covering surgeon fees, OT + gas charges, anaesthesia (18% of surgeon fee), assistant surgeon charges (15% of surgeon fee), and CSSD (sterilisation). Room charges, medicines, blood products, and investigations are billed separately.
| Surgery Grade | Economy Room | Twin Sharing | Single Room | Deluxe Room |
|---|---|---|---|---|
| GRADE 6 (Simpler procedures) | ₹1,66,565 | ₹2,49,848 | ₹3,24,802 | ₹4,06,002 |
| GRADE 7 (Standard cancer surgeries) | ₹2,35,859 | ₹3,06,616 | ₹3,98,601 | ₹4,58,391 |
| GRADE 8 (Radical hysterectomy, complex staging) | ₹2,83,029 | ₹3,96,241 | ₹4,95,301 | ₹5,44,832 |
Important Notes on the Surgery Package
These are the surgery package amounts only — they do not include room charges per night, medicines, blood products, or investigations. Emergency surgery (8 PM–8 AM, Sundays, hospital holidays): 25% surcharge. Robotic-assisted surgery: ₹1.25 lakh additional surcharge over the relevant grade package. Multiple surgeries at the same time by the same surgeon: full charge for the major surgery, 50% for the second procedure. Written cost estimates are provided to every patient before admission.
Cost of Chemotherapy for Gynaecological Cancer in India
Chemotherapy is the second major cost centre after surgery. The cost of each chemotherapy cycle depends on which drugs are used — ranging from the affordable carboplatin + paclitaxel combination for ovarian and endometrial cancer, to the significantly more expensive targeted therapies and PARP inhibitors.
| Chemotherapy Regimen | Cost Per Cycle | Full Course Duration & Total Cost | Key Information |
|---|---|---|---|
| Carboplatin + Paclitaxel Standard Ovarian/Endometrial Cancer | ₹25,000–50,000 per cycle | 6 cycles (18 weeks) Total: ₹1.5–3 lakhs | Most commonly used first-line chemotherapy for ovarian, endometrial, and fallopian tube cancers. Administered every 3 weeks as IV infusion over 3–4 hours. Day-care outpatient procedure at Shree Hospitals. |
| Cisplatin (Weekly) Cervical Cancer CCRT | ₹5,000–15,000 per week | 5–6 weeks concurrent with radiotherapy Total: ₹25,000–90,000 | Weekly low-dose cisplatin (40 mg/m²) administered concurrently with external beam pelvic radiotherapy for locally advanced cervical cancer. Comparatively affordable — the higher cost is typically the radiotherapy infrastructure. |
| Bevacizumab Anti-VEGF Targeted Therapy — Ovarian Cancer | ₹60,000–1,20,000 per cycle | 15–22 cycles Total: ₹9–26 lakhs | Added to carboplatin + paclitaxel in Stage IV and high-risk Stage III ovarian cancer, continued as maintenance. Significantly increases total cost — important for insurance planning. |
| Olaparib / Niraparib PARP Inhibitor Maintenance — BRCA+ Ovarian Cancer | ₹80,000–1,50,000 per month | 24 months (standard) Total: ₹19–36 lakhs (substantial subsidies available) | Oral tablet taken daily. The most impactful recent advance in ovarian cancer — dramatically extends progression-free survival in BRCA-positive patients. Patient access programmes, AstraZeneca subsidies, and insurance coverage significantly reduce real-world cost. |
| Pembrolizumab Immunotherapy — MSI-High/dMMR Cancers | ₹2,50,000–4,00,000 per cycle | 6–12+ cycles Total: ₹15–48 lakhs | For MSI-high endometrial or cervical cancer. Very high cost — PMJAY/insurance coverage is essential for access. Molecular testing (MSI/MMR status) required before prescribing. |
| Carboplatin + Gemcitabine Platinum-Sensitive Recurrence | ₹30,000–60,000 per cycle | 6 cycles Total: ₹1.8–3.6 lakhs | Used for recurrent ovarian cancer that recurs more than 6 months after completing first-line platinum chemotherapy. Often combined with bevacizumab. |
Outpatient vs Inpatient Chemotherapy — The Cost Difference
Most chemotherapy for gynaecological cancer at Shree Hospitals is administered as an outpatient day-care procedure — the patient attends the chemotherapy suite, receives the infusion over 3–6 hours, and returns home the same day. This significantly reduces cost compared to inpatient administration (which would add room charges for each chemotherapy day). No room charge applies for outpatient day-care chemotherapy — only the chemotherapy administration fee and drug cost.
India vs the World — The Cost Advantage You Need to Know
The international medical tourism landscape recognises India as one of the most cost-effective destinations for high-complexity cancer surgery. For gynaecological cancer specifically — where outcomes are most dependent on the quality of the first surgical procedure — India's top centres deliver equivalent results at 85–96% lower cost than the USA. This is not a compromise. It is the most important financial truth available to any Indian woman facing a gynaecological cancer diagnosis.
| Procedure / Treatment | India (Shree Hospitals) | USA | UK (Private) | Singapore | India Saves vs USA |
|---|---|---|---|---|---|
| Radical Hysterectomy + Lymphadenectomy | ₹2.83–5.99L | ₹48–80L ($58,000–96,000) | ₹30–55L (£29,000–53,000) | ₹20–35L (SGD $34,000–60,000) | 85–94% |
| Complete Cytoreductive Surgery (Ovarian Cancer Debulking) | ₹4.08–8.63L | ₹65–1.20Cr ($78,000–145,000) | ₹40–75L (£38,000–72,000) | ₹25–50L (SGD $43,000–86,000) | 87–95% |
| Carboplatin + Paclitaxel (6 Cycles) | ₹1.5–3L | ₹12–20L ($14,000–24,000) | ₹10–16L (£9,600–15,000) | ₹5–10L (SGD $8,000–17,000) | 82–92% |
| Robotic-Assisted Radical Hysterectomy | ₹4.08–7.24L (incl. robotic surcharge) | ₹55–95L ($66,000–114,000) | ₹35–60L (£34,000–58,000) | ₹22–40L (SGD $38,000–68,000) | 87–94% |
| PARP Inhibitor Maintenance (Olaparib — 24 months) | ₹19–36L (with subsidies) | ₹85–1.65Cr ($100,000–200,000) | ₹50–90L (£48,000–87,000) | ₹30–60L (SGD $52,000–103,000) | 72–89% |
| Total Comprehensive Treatment (Surgery + 6 Chemo cycles + Follow-up) | ₹5–18L | ₹80–2.50Cr ($96,000–300,000) | ₹50–1.40Cr (£48,000–135,000) | ₹30–80L (SGD $52,000–138,000) | 89–96% |
Why India Has a Structural Cost Advantage — Without Compromising Quality
- Medical education and training: India trains large numbers of specialist surgeons including Gynecologic Oncologists who work within the Indian healthcare pricing structure — even when their training and skills are internationally equivalent
- Generic pharmaceutical industry: India is the world's largest manufacturer of generic medicines. Chemotherapy drugs are available at 40–80% less than in the USA or UK
- Hospital infrastructure costs: Land, construction, and operational costs for Indian hospitals are dramatically lower than in the USA or UK
- Staffing costs: India's lower cost of living means equivalent-quality clinical staffing is maintained at lower cost
- The outcome equivalence: When a Gynecologic Oncologist at Shree Hospitals achieves complete cytoreduction in a Stage III ovarian cancer patient — the same surgical benchmark as a MSKCC or Royal Marsden-trained oncosurgeon — the difference in cost has no corresponding difference in survival outcome
Robotic Cancer Surgery at Shree Hospitals — Medbot Toumai Costs & Benefits
Shree Hospitals is home to the Medbot Toumai Dual Console robotic surgical system — one of a select few hospitals in India with in-house robotic gynaecological oncology capability. Dr. Jay Mehta leads this programme, performing radical hysterectomies, staging laparoscopies, sentinel lymph node procedures, and complex pelvic oncology surgery through the robotic console.
| Item | Details |
|---|---|
| Standard Open or Laparoscopic Surgery Package | Included in Grade 6–8 standard tariff (as shown in the surgery packages table). No additional surgical platform charge. |
| Robotic-Assisted Surgery Surcharge (Medbot Toumai Dual Console) | Approximately ₹1,25,000 (₹1.25 lakhs) additional charge over the standard surgery package. Example: Grade 8 surgery (Single room) = ₹4,95,301 + Robotic surcharge ₹1,25,000 = approximately ₹6,20,000 all-in for robotic-assisted radical hysterectomy. |
| What the ₹1.25 Lakh Robotic Surcharge Covers | Use of the Medbot Toumai Dual Console robotic surgical platform; robotic instrument consumables (single-use robotic arms and instruments); dedicated robotic surgical nursing and perfusion team; robotic surgical time; post-operative monitoring by Dr. Mehta as the console surgeon. |
| Clinical Benefits Justifying the Robotic Surcharge | Smaller incisions (5 tiny cuts vs 20–25 cm open incision); less blood loss (average 50–100 mL vs 300–700 mL for open); shorter hospital stay (1–2 days vs 5–7 days — reducing room charges); faster return to chemotherapy (2–3 weeks vs 6–8 weeks for open); superior 3D magnified visualisation for nerve-sparing and lymph node dissection. In many cases, the reduced hospital stay cost partially offsets the robotic surcharge. |
| Surgeries Offered Robotically at Shree Hospitals | Radical hysterectomy (cervical cancer); total hysterectomy + BSO + staging (endometrial cancer); staging laparoscopy + omentectomy for early ovarian cancer; sentinel lymph node mapping; radical trachelectomy (fertility-preserving); and complex adhesiolysis in endometriosis and cancer recurrence cases. |
| Insurance Coverage for Robotic Surcharge | Most standard health insurance policies do not specifically cover robotic surgical surcharges. Some premium health insurance plans and corporate group health policies cover robotic surgery as part of the overall surgical claim. Check your policy document specifically for 'robotic surgery' or 'surgical technique' exclusions. The standard surgery package is generally covered — the robotic surcharge may require self-pay or special policy endorsement. |
Does Insurance Cover Gynaecological Cancer Treatment? — What You Must Know
Health insurance in India covers cancer treatment — but incompletely, unevenly, and with critical exclusions that patients are often unaware of until they are in the middle of treatment. Understanding your insurance coverage before a diagnosis is the single most important financial planning step any woman can take.
| Insurance Type | Coverage Level for Cancer | What It Covers and Key Points |
|---|---|---|
| Basic Mediclaim / Hospitalisation Insurance (Star Health, New India, United India) | Usually Partial | Covers surgery (inpatient hospitalisation), ICU charges, surgeon fees, and basic IV chemotherapy. Generally DOES NOT cover: targeted therapy (bevacizumab), PARP inhibitors, outpatient chemotherapy, oral chemotherapy tablets (olaparib), radiotherapy in many plans. Sub-limits often apply for room rent, ICU, and surgeon fees. |
| Critical Illness Insurance / Cancer Rider (HDFC Life Cancer Care, LIC Critical Illness) | Lump Sum — Comprehensive | Pays a lump-sum amount on cancer diagnosis — typically ₹10–50 lakhs depending on sum insured. No itemised billing — the entire lump sum is paid directly to the patient on histologically confirmed diagnosis. Can be used for any cancer-related expense including chemotherapy, targeted therapy, ICU, home nursing, lost income, and travel. Most valuable insurance for cancer specifically. |
| Cancer-Specific Health Insurance (Star Cancer Care Gold, HDFC Ergo Cancer Protect) | High — Specifically Designed | Purpose-built cancer insurance products covering: initial diagnosis, surgery, chemotherapy (including targeted therapy and immunotherapy), radiotherapy, palliative care, and second medical opinions. Some also cover: home nursing, counselling, and wigs/prosthetics from hair loss. The most comprehensive cancer-care insurance products available in India. |
| Ayushman Bharat — PMJAY (Government Scheme) | Up to ₹5 Lakhs per family per year | India's national health insurance scheme for the bottom 40% economically. Covers cancer treatment including surgery and chemotherapy at empanelled hospitals. Gynaecological cancer surgeries are specifically included in the HBP (Health Benefit Package) under PMJAY. Check eligibility at pmjay.gov.in. Ask specifically at Shree Hospitals billing about PMJAY eligibility. |
| State Government Health Schemes (MJPJAY — Maharashtra) | Variable — State Specific | Many Indian states have their own government health insurance schemes supplementing PMJAY. Maharashtra's MJPJAY covers cancer treatment including surgery and chemotherapy for eligible residents. Check with the state health department or at Shree Hospitals billing counter for current eligibility. |
| Corporate / Group Health Insurance | Variable — Policy Specific | Group health insurance provided by employers typically offers broader coverage than individual policies — with higher room rent limits and sometimes targeted therapy. Review your HR-provided policy document carefully, particularly the exclusions section for cancer, and pre-authorise major treatments proactively. |
| No Insurance (Self-Pay) | Full Out-of-Pocket | EMI / payment plan options through hospital, NBFC medical loans, and bank medical loans. Shree Hospitals billing team provides detailed itemised estimates before treatment begins. Financial counselling to identify any government scheme eligibility is offered at the time of admission. |
EMI and Financing Options for Cancer Treatment
A cancer diagnosis should never mean a delay in treatment due to financial constraints. Multiple financing mechanisms are available in India to ensure that patients can begin treatment immediately and manage the financial burden through manageable monthly payments. At Shree Hospitals, the billing team actively counsels every cancer patient on available financing options at the time of admission planning.
| EMI / Financing Option | Interest Rate & Tenure | How to Access and Key Details |
|---|---|---|
| Shree Hospitals Internal Payment Plan | Interest-free instalments for 3–6 months (select cases); extended payment plans with low interest | Available for patients with confirmed cancer diagnosis and clear treatment plan. Arranged through the Shree Hospitals billing and finance team. A minimum initial deposit is required, with the balance spread across agreed monthly instalments. Eligibility assessed case-by-case. Speak to the billing counsellor at the time of admission planning. |
| Bajaj Finserv Health EMI Card | 0% interest for 3–12 months; extended tenures at low interest (12–24 months) | Widely accepted at major private hospitals including Shree Hospitals. Provides instant approval for medical treatment financing. 0% interest available for 3, 6, 9, and 12-month EMI plans. For larger amounts (₹5–15 lakhs), longer tenures with low interest (12–15% per annum) are available. Apply online or at the Bajaj Finserv counter at the hospital. |
| Mediloan (Tata Capital / Other NBFCs) | 12–18% per annum; tenures up to 5 years | Specialised medical loan products from NBFCs (Non-Banking Financial Companies). Documentation: photo ID, address proof, 3 months bank statements, treatment estimate. Approval in 24–48 hours. Flexible repayment up to 60 months. |
| Bank Medical / Personal Loans (SBI, HDFC, ICICI, Axis) | 10–16% per annum; amounts up to ₹25 lakhs | All major Indian banks offer personal loans for medical treatment. Some (e.g. SBI Kavach Personal Loan) offer specific medical loan products at preferential rates. Generally requires proof of income (salary slips / ITR), credit score >700, and medical treatment documentation. Process time: 3–7 working days. |
| Credit Card EMI Conversion | 0% interest for 3–6 months at many hospitals; flat interest rates on longer tenures | Many private hospitals including Shree Hospitals have tie-ups with major banks (HDFC, ICICI, SBI, Axis) for 0% EMI conversion of medical bills on credit cards. Best for smaller amounts (₹50,000–3,00,000). Easy process at the billing counter — no additional documentation. |
| Government Assistance — PM-JAY & CMCHIS | Eligibility-based coverage up to ₹5 lakhs — no EMI required | Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (PMJAY) and Chief Minister's Comprehensive Health Insurance Schemes in various states provide cashless coverage for eligible families. Bills are settled directly between the hospital and the government scheme. Check eligibility through the Shree Hospitals empanelment desk before admission. |
How to Select Health Insurance That Will Actually Cover Your Cancer Care
The most powerful financial protection a woman can have against the cost of gynaecological cancer is an insurance policy that covers her effectively — purchased before she is diagnosed. The guidance below applies to both current insurance review and future policy selection.
Check cancer treatment coverage — not just hospitalisation
Always specifically ask: 'Does this policy cover outpatient chemotherapy, targeted therapy, and oral anticancer drugs?' If the answer is no — consider adding a cancer rider. For a serious cancer like ovarian cancer requiring surgery + 6 cycles carboplatin/paclitaxel + possible maintenance PARP inhibitor, the total cost over 2 years can easily reach ₹20–40 lakhs without subsidies.
Sum Insured — The higher, the better for cancer
Cancer treatment often requires multiple hospitalisations (for surgery, post-operative complications, chemotherapy sessions, and recurrence). A policy with restoration benefit (where the sum insured is restored if exhausted during the policy year) is critically important for cancer patients. Also check that making claims does not reduce coverage in subsequent years.
Room rent sub-limits — the hidden trap
Choose a policy with no room rent sub-limit, or with a sum insured that adequately covers the room category you wish to use. At Shree Hospitals, room options range from Economy (₹1,500–2,500/night) to Suite (₹10,000–15,000/night) — your insurance policy should cover your preferred room category without triggering proportional deductions on the entire bill.
Pre-existing disease waiting period — the most critical warning
Once a cancer diagnosis is confirmed, getting new cancer treatment coverage becomes very difficult. Women with a family history of ovarian, endometrial, or cervical cancer should add a cancer-specific plan (Star Cancer Care Gold, Aditya Birla Activ Cancer Secure, HDFC Ergo Cancer Protect, Max Bupa CritiCare) to their existing health insurance immediately — without waiting for a personal diagnosis to trigger the decision.
Government scheme eligibility — check before paying a single rupee
These schemes cover surgery and chemotherapy at empanelled hospitals. For eligible families, cancer treatment may be cashless with zero out-of-pocket cost up to ₹5 lakhs per family per year. Government scheme eligibility is checked before any private payment is requested at Shree Hospitals — this is our policy.
Total Treatment Cost Estimates — What to Budget From Diagnosis to Recovery
The table below provides realistic total treatment cost estimates for the most common gynaecological cancer diagnoses — combining the Shree Hospitals surgical tariff with estimated chemotherapy and radiotherapy costs. These are estimates for planning purposes; actual costs are determined at the time of detailed clinical assessment.
| Cancer Type & Stage | Surgery Cost (Shree Hospitals) | Chemotherapy / Radiotherapy Cost | Total Estimated Treatment Cost and Key Notes |
|---|---|---|---|
| Early Cervical Cancer (Stage IA2–IB1) Laparoscopic Radical Hysterectomy | ₹3.98–5.04L (Grade 7–8, Single room) +₹1.25L robotic = ₹5.23–6.29L | None typically (adjuvant brachy if needed: ₹40,000–80,000) | Total: ₹5.25–7L. Excellent prognosis — most Stage IA–IB1 patients are cured with surgery alone. If adjuvant brachytherapy required: add ₹40,000–80,000. |
| Advanced Cervical Cancer (Stage IIB–IVA) CCRT — No Surgery | Radiotherapy course: ₹60,000–1,50,000 (EBRT 25 fractions + brachytherapy) | Concurrent cisplatin: ₹25,000–90,000 (5–6 weeks) | Total CCRT: ₹85,000–2.4L. Significantly more affordable than surgery for this stage. No surgical admission cost. |
| Early Endometrial Cancer (Stage I–II) Laparoscopic Hysterectomy + BSO | ₹2.36–3.99L (Grade 7, Economy–Single) +₹1.25L robotic option = ₹3.61–5.24L | None for Stage IA Grade 1–2 Brachytherapy if intermediate/high risk: ₹40,000–80,000 | Total: ₹2.36–6L. Excellent prognosis — Stage I endometrial cancer has >90% 5-year survival. Most women treated for Stage I return to normal life within 4–6 weeks. |
| Early Ovarian Cancer (Stage IA–IC) Laparoscopic Surgical Staging | ₹2.83–4.95L (Grade 8, Economy–Single) +Robotic option ₹1.25L | Carboplatin + paclitaxel 3–6 cycles: ₹75,000–3L | Total: ₹3.5–8L. Excellent prognosis if complete staging confirms Stage I — 5-year survival >90%. Complete surgical staging is essential to confirm Stage I and avoid over- or under-treatment. |
| Advanced Ovarian Cancer (Stage IIIC–IV) Debulking + NACT + Maintenance | Surgery (Group I/Complex): ₹4.08–8.63L (ICU typically required) | NACT: ₹1.5–3L (3 cycles pre-surgery) Post-surgical chemo: ₹75,000–1.5L PARP inhibitor maintenance: ₹19–36L (or subsidised) | Total without PARP inhibitor: ₹6.5–13L. With olaparib maintenance (BRCA positive): significant additional cost — essential to access the AstraZeneca patient assistance programme or insurance. The most expensive gynaecological cancer to treat comprehensively — plan early. |
Why Women Across India Choose Shree Hospitals for Gynaecological Cancer Surgery
Every year, women from Maharashtra, Gujarat, Rajasthan, Madhya Pradesh, Chhattisgarh, and many other states travel to Shree Hospitals in Mumbai for gynaecological cancer surgery. This choice is driven by a clear understanding that not all cancer surgery is equivalent — and that the institution and surgeon matter profoundly.
| Clinical and Financial Excellence Factor | Why It Matters for Your Treatment and Your Budget |
|---|---|
| Full-Time MCH Gynecologic Oncosurgeon with Dr. Jay Mehta | The quality of the first surgery for ovarian and cervical cancer is the single most important determinant of long-term survival. Dr. Jay Mehta is an internationally recognised Minimally Invasive Surgeon with massive experience and LIVE demonstrations of cancer surgeries. A complete cytoreduction at first surgery (zero visible disease) saves the patient the cost and trauma of recurrence surgery and salvage chemotherapy — which collectively cost far more than doing the first surgery correctly. |
| Medbot Toumai Dual Console Robotic Surgery — In-House | Shree Hospitals is one of the few hospitals in India with in-house Medbot Toumai Dual Console robotic surgery dedicated to gynaecological oncology. Shorter hospital stay (1–2 days vs 5–7 days), faster recovery (3 weeks vs 8 weeks), less blood loss, and earlier commencement of chemotherapy. The ₹1.25 lakh robotic surcharge is partially offset by reduced hospital stay costs. |
| Tertiary Level ICU — Full Post-Operative Critical Care | Complex ovarian cancer debulking surgery requiring bowel resection, diaphragm stripping, or splenectomy needs the highest level of post-operative critical care. Shree Hospitals maintains a fully equipped, 24-hour consultant-staffed tertiary ICU. A hospital that performs complex cancer surgery without adequate ICU infrastructure is not a complete cancer surgical centre. ICU packages are clearly itemised in the tariff for patient planning. |
| In-House Testing and Radiology — No External Referral Delays | CA-125, HE4, ROMA score, and all standard tumour markers processed in-house with same-day results. Transvaginal ultrasound, pelvic and abdominal MRI, CT abdomen and pelvis — all in-house. For patients from other states who travel to Shree Hospitals for surgery, a complete pre-operative staging work-up (TVS + MRI + CT + tumour markers) can be performed in a single day — avoiding multiple hospital visits and reducing the total cost of the pre-operative assessment. |
| Cost Transparency and Ethical Billing — No Hidden Charges | Every patient receives a written surgical estimate before admission. The estimate itemises: surgery grade and package, room category, ICU charges if applicable, robotic surcharge if applicable, and estimated ancillary costs. No pressure to upgrade to a more expensive room category. All three government scheme eligibilities (PMJAY, MJPJAY, CGHS) are checked before any private payment is requested. This ethical approach to billing reflects the department's patient-first philosophy. |
| Dedicated Gynecologic Oncology Department — Complete Care Pathway | The complete cancer care continuum under one roof: CA-125 + HE4 (in-house), transvaginal ultrasound, pelvic MRI, staging CT, tumour board discussion (MDT), surgery (open, laparoscopic, or robotic), post-operative ICU, chemotherapy coordination, and 5-year surveillance programme. No patient needs to be referred to another hospital for any component of standard gynaecological cancer care. |
A Note on Cost Transparency from the Shree Hospitals Team
At Shree Hospitals, we believe that a cancer patient should never face a financial surprise on top of a medical crisis. Every patient who is planning surgery with Dr. Mehta receives a written, itemised cost estimate before any procedure is agreed. Our billing team checks PMJAY, MJPJAY, and CGHS eligibility for every admitted patient. Our policy is simple: the best cancer treatment should be available to every woman who needs it — regardless of her economic circumstances.
Frequently Asked Questions — Cancer Treatment Costs in India
What is the average cost of gynaecological cancer surgery in India at a Tier 1 city hospital?
Surgeries in Grade 6 (simpler procedures) start at ₹1,66,565 (Economy room). Standard cancer surgeries in Grade 8 range from ₹2,83,029 (Economy) to ₹5,44,832 (Deluxe). For a complete all-in treatment estimate specific to your diagnosis, please call Shree Hospitals at +91-9920914115. Written estimates are provided before every admission.
What is the average cost of chemotherapy for gynaecological cancer in India?
The widest variation in cost comes from targeted therapy and maintenance treatment — discuss your specific eligibility and patient access programmes with Dr. Mehta. For standard carboplatin + paclitaxel chemotherapy at Shree Hospitals, a full projected chemotherapy cost estimate is provided at the time of treatment planning — so patients know the complete treatment cost before committing to therapy.
Does health insurance cover gynaecological cancer treatment completely?
Recommendation: A combination of basic health insurance (₹10–15 lakhs) + a cancer-specific plan + a critical illness rider provides the most comprehensive cancer coverage for most Indian families. Buy all policies BEFORE any diagnosis — once a cancer diagnosis is confirmed, getting new cancer treatment coverage becomes very difficult.
Why is cancer surgery in India much cheaper than in the USA or UK?
The structural factors: doctor remuneration in India does not reflect the US liability-driven billing environment; hospital land and construction costs are dramatically lower; generic chemotherapy drugs in India are 40–80% cheaper than in the USA (India has the world's largest generic pharmaceutical industry); and equivalent-quality clinical staffing is maintained at lower cost due to India's lower cost of living. The surgical skill and subspecialty training of Indian Gynecologic Oncosurgeons is internationally equivalent.
What is included in the Shree Hospitals surgery package?
At Shree Hospitals, a complete all-in admission estimate — covering all of the above plus anticipated ancillary costs — is provided in writing before admission. You will not be surprised by the final bill. This estimate is prepared by the billing team in consultation with Dr. Mehta's clinical assessment and is the cornerstone of our cost transparency commitment.
Can I get robotic cancer surgery in Mumbai? How much extra does it cost?
Benefits of robotic surgery: 5 tiny incisions vs open surgery, less blood loss, shorter hospital stay (1–2 days vs 5–7 days), faster recovery, earlier start of chemotherapy, and superior surgical precision in nerve-sparing and lymph node dissection. The reduced hospital stay (saving 3–5 nights of room and nursing charges) partially offsets the robotic surcharge. Call +91-9920914115 for a specific robotic surgery cost estimate for your diagnosis.
Are there any EMI options available for cancer treatment at Shree Hospitals?
Please speak to the Shree Hospitals billing team before admission to arrange the most suitable financing option. Check PMJAY / MJPJAY eligibility first — if eligible, treatment may be cashless with no EMI required. The billing counsellor at Shree Hospitals is trained to identify the best available financing mechanism for each family's specific circumstances.
Can women from other states like Gujarat or Rajasthan get surgery at Shree Hospitals?
Shree Hospitals provides: a pre-surgery online consultation with Dr. Mehta (video call) so that surgical planning and all pre-operative investigations can be reviewed before travelling to Mumbai; coordination of all pre-operative staging investigations in a single day of admission; family accommodation guidance for relatives; and telemedicine follow-up for post-discharge surveillance — minimising return visits to Mumbai. Room options range from Economy (₹1,500–2,500/night) to Suite (₹10,000–15,000/night), allowing women from all economic backgrounds to access identical surgical quality.
Should I go abroad for cancer surgery or stay in India?
The key determinant of outcome is the surgeon's subspecialty training and experience — not the country. Dr. Jay Mehta has equivalent training to Western Gynecologic Oncologists and demonstrates live surgical techniques internationally. Going to Singapore is only 60–70% cheaper than the USA — still 4–10 times more expensive than India. Concern about quality is legitimate — but it is addressed by choosing the RIGHT hospital in India, not by going abroad.
What government schemes are available for cancer treatment in India?
Check PMJAY eligibility at pmjay.gov.in or at the Shree Hospitals PMJAY desk — the hospital billing team checks eligibility before any private payment is requested. Many states (Tamil Nadu, Gujarat, Andhra Pradesh, etc.) have their own cancer treatment schemes — check with the state health department. Dr. Mehta's team navigates pharmaceutical patient assistance programmes for eligible patients — these can significantly reduce the real-world cost of PARP inhibitors and targeted therapy.
What is the total cost of ovarian cancer treatment from start to finish?
The widest variation in cost comes from targeted therapy and maintenance treatment. For patients who are BRCA-positive and eligible for olaparib maintenance — the AstraZeneca patient assistance programme significantly reduces the real-world cost. Insurance planning before starting treatment is essential. Dr. Mehta's team provides a complete treatment cost roadmap at the time of diagnosis and treatment planning — so there are no financial surprises.
How can I get a cost estimate before committing to surgery at Shree Hospitals?
To get your estimate today: Call +91-9920914115 or 18002684000. Online consultation is available for women from other cities and states. The written estimate covers every cost component — there are no surprises at the final billing stage. This is the standard at Shree Hospitals — and it is guaranteed.
💰 Financial Planning for Cancer Treatment — Do Not Overlook These
Act on These Immediately:
- You have been diagnosed with a gynaecological cancer and have NOT yet received a written surgical cost estimate — always ask for this before agreeing to surgery
- Your hospital has not discussed your insurance coverage before admission — pre-authorisation for cancer surgery should be arranged before the procedure
- You are self-paying (no insurance) and have not been told about EMI / payment plan options — ask specifically about this at the billing department
- You are paying for chemotherapy cycle-by-cycle without a complete treatment plan estimate — insist on a projected full-course cost estimate before starting
- Your insurance has rejected a chemotherapy claim — escalate to your insurance ombudsman immediately; cancer claim rejections are frequently overturned on appeal
- You are considering cancer treatment abroad because you think India cannot provide the same quality — India's top Gynecologic Oncology centres offer identical clinical outcomes at a fraction of the international cost
- Your Ayushman Bharat (PMJAY) card has not been checked for eligibility at Shree Hospitals — if eligible, you may be entitled to up to ₹5 lakhs of cancer treatment coverage at zero out-of-pocket cost
- You are deciding between hospitals based on price alone — cost transparency, surgical expertise, and post-operative ICU capability all affect outcomes and total cost
Get Your Written Cost Estimate — Contact Shree Hospitals Today
Knowing the cost of treatment before you commit to a centre is your right as a patient. At Shree Hospitals, we provide written surgical estimates before admission, clearly itemise all cost components, and actively help patients access insurance pre-authorisation, government scheme eligibility, and financing options. Online consultation with Dr. Jay Mehta is available for women from other cities and states.
✅ Written Estimate Before Surgery ✅ No Hidden Charges ✅ Insurance & EMI Guidance ✅ Medbot Toumai Robotic Surgery ✅ PMJAY Empanelled
© Department of Gynecologic Oncology, Shree Hospitals, Mumbai, India. All rights reserved. Content may not be reproduced without written permission. | Primary keyword: cost gynaecological cancer treatment India | Secondary: radical hysterectomy cost Mumbai India, chemotherapy cost India, gynaecological oncology cost Mumbai | LSI Location: cancer surgery cost India 2026, Shree Hospitals surgical tariff
